Correlation Between Travere Therapeutics and Vaxxinity
Can any of the company-specific risk be diversified away by investing in both Travere Therapeutics and Vaxxinity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Travere Therapeutics and Vaxxinity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Travere Therapeutics and Vaxxinity, you can compare the effects of market volatilities on Travere Therapeutics and Vaxxinity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Travere Therapeutics with a short position of Vaxxinity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Travere Therapeutics and Vaxxinity.
Diversification Opportunities for Travere Therapeutics and Vaxxinity
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Travere and Vaxxinity is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Travere Therapeutics and Vaxxinity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxxinity and Travere Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Travere Therapeutics are associated (or correlated) with Vaxxinity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxxinity has no effect on the direction of Travere Therapeutics i.e., Travere Therapeutics and Vaxxinity go up and down completely randomly.
Pair Corralation between Travere Therapeutics and Vaxxinity
If you would invest 1,732 in Travere Therapeutics on December 30, 2024 and sell it today you would earn a total of 236.00 from holding Travere Therapeutics or generate 13.63% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Travere Therapeutics vs. Vaxxinity
Performance |
Timeline |
Travere Therapeutics |
Vaxxinity |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Travere Therapeutics and Vaxxinity Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Travere Therapeutics and Vaxxinity
The main advantage of trading using opposite Travere Therapeutics and Vaxxinity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Travere Therapeutics position performs unexpectedly, Vaxxinity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxxinity will offset losses from the drop in Vaxxinity's long position.Travere Therapeutics vs. Cytokinetics | Travere Therapeutics vs. Ventyx Biosciences | Travere Therapeutics vs. Cogent Biosciences | Travere Therapeutics vs. Nuvalent |
Vaxxinity vs. Tarsus Pharmaceuticals | Vaxxinity vs. Aldeyra | Vaxxinity vs. Travere Therapeutics | Vaxxinity vs. Eton Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |